MSI2

RNA-binding protein Musashi homolog 2 · Q96DH6 · MSI2 on Sugi Atlas →

0 patent compounds predicted against MSI2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MSI2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer PHASE4UNKNOWN
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes PHASE2COMPLETED
Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System PHASE2WITHDRAWN
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors PHASE1RECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Current Microsatellite Stability Results in Colon Cancer nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Role of CD133 & Microsatellite Status in Evaluation of Rectosigmoid Cancer Young Adults Received Neoadjuvant Treatment nanUNKNOWN
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED
Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome nanRECRUITING
A Study of Multilocus Methylation Abnormalities in Subjects With Imprinting Disorders nanNOT_YET_RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development nanCOMPLETED
Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG nanACTIVE_NOT_RECRUITING
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors nanUNKNOWN
Target of Suv420h1/2 in Hepatocytes nanRECRUITING
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
The Molecular Pathogenesis Study of Cataract nanUNKNOWN
Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage nanUNKNOWN
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction nanCOMPLETED
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
Non-Invasive Diagnosis of Endometrial Cancer nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a MSI2 binder may also engage these)

ProteinNameSimilarity
Q920Q6 1.000 Q920Q6 →
Q61474 0.993 Q61474 →
Q9C652 0.992 Q9C652 →
O43347 0.992 O43347 →
Q8K3P4 0.992 Q8K3P4 →
Q9VVE5 0.991 Q9VVE5 →
G5EFS2 0.988 G5EFS2 →
O14102 0.987 O14102 →
DAZAP1 DAZ-associated protein 1 0.987 landscape →
Q98SJ2 0.987 Q98SJ2 →
Q6DEY7 0.986 Q6DEY7 →
PABPC4 Polyadenylate-binding protein 4 0.986 landscape →
Q05196 0.986 Q05196 →
Q5R8F7 0.985 Q5R8F7 →
Q3SWU3 0.985 Q3SWU3 →
Q6GR16 0.985 Q6GR16 →
Q98SP8 0.985 Q98SP8 →
Q7TP47 0.984 Q7TP47 →
P70318 0.984 P70318 →
Q9JII5 0.984 Q9JII5 →
SYNCRIP Heterogeneous nuclear ribonucleoprotein Q 0.983 landscape →
Q9EPH8 0.983 Q9EPH8 →
Q7TMK9 0.983 Q7TMK9 →
Q9H361 0.983 Q9H361 →
Q2HJG2 0.983 Q2HJG2 →
O64380 0.983 O64380 →
A2Q848 0.982 A2Q848 →
Q5ZI72 0.982 Q5ZI72 →
Q4VXU2 0.981 Q4VXU2 →
Q9ZQA8 0.981 Q9ZQA8 →